Tang K - Search Results

1

Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer.

Li Y, Liu C, Tang K, Chen Y, Tian K, Feng Z, Chen J. Li Y, et al. Among authors: tang k. Mol Med Rep. 2018 Feb;17(2):2373-2383. doi: 10.3892/mmr.2017.8179. Epub 2017 Nov 28. Mol Med Rep. 2018. PMID: 29207185 Free PMC article.

2

Function of Aurora kinase A in Taxol-resistant breast cancer and its correlation with P-gp.

Li Y, Tang K, Zhang H, Zhang Y, Zhou W, Chen X. Li Y, et al. Among authors: tang k. Mol Med Rep. 2011 Jul-Aug;4(4):739-46. doi: 10.3892/mmr.2011.494. Epub 2011 May 16. Mol Med Rep. 2011. PMID: 21584498

3

The effect of Aurora kinases on cell proliferation, cell cycle regulation and metastasis in renal cell carcinoma.

Li Y, Zhou W, Wei L, Jin J, Tang K, Li C, Teh BT, Chen X. Li Y, et al. Among authors: tang k. Int J Oncol. 2012 Dec;41(6):2139-49. doi: 10.3892/ijo.2012.1633. Epub 2012 Sep 20. Int J Oncol. 2012. PMID: 23007526

4

[Identification of two small molecule inhibitors of hypoxia-inducible factor 1 with different cell-based screening model].

Lang L, Tang K, Li Y, Liu X, Wang C, Chen X. Lang L, et al. Among authors: tang k. Zhongguo Zhong Yao Za Zhi. 2012 Jul;37(14):2151-5. Zhongguo Zhong Yao Za Zhi. 2012. PMID: 23126204 Chinese.

5

Synthesis and in vitro antitumor activities of novel benzyl urea analogues of sorafenib.

Lu CS, Tang K, Li Y, Jin B, Yin DL, Ma C, Chen XG, Huang HH. Lu CS, et al. Among authors: tang k. Yao Xue Xue Bao. 2013 May;48(5):709-17. Yao Xue Xue Bao. 2013. PMID: 23888694

6

Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agents.

Lu C, Tang K, Li Y, Li P, Lin Z, Yin D, Chen X, Huang H. Lu C, et al. Among authors: tang k. Eur J Med Chem. 2014 Apr 22;77:351-60. doi: 10.1016/j.ejmech.2014.03.020. Epub 2014 Mar 12. Eur J Med Chem. 2014. PMID: 24675135

7

The study of a novel sorafenib derivative HLC-080 as an antitumor agent.

Tang K, Luo C, Li Y, Lu C, Zhou W, Huang H, Chen X. Tang K, et al. PLoS One. 2014 Jul 8;9(7):e101889. doi: 10.1371/journal.pone.0101889. eCollection 2014. PLoS One. 2014. PMID: 25004130 Free PMC article.

8

[Anti-tumor activity and mechanism of T03 in vitro and in vivo].

Tang K, Yang HZ, Li Y, Tian K, Li C, Zhou WQ, Niu F, Feng ZQ, Chen XG. Tang K, et al. Yao Xue Xue Bao. 2014 Jun;49(6):861-8. Yao Xue Xue Bao. 2014. PMID: 25212033 Chinese.

9

[Synthesis and biological evaluation of 2-(3-butynoicamidophenyl) benzothiazole derivatives as antitumor agents].

Yin GL, Li Y, Tang K, Jin XF, Chen XG, Li L, Feng ZQ. Yin GL, et al. Among authors: tang k. Yao Xue Xue Bao. 2014 Jun;49(6):888-95. Yao Xue Xue Bao. 2014. PMID: 25212037 Chinese.

10

The molecular mechanisms of a novel multi-kinase inhibitor ZLJ33 in suppressing pancreatic cancer growth.

Li Y, Tang K, Zhang L, Li C, Niu F, Zhou W, Yang H, Feng Z, Chen X. Li Y, et al. Among authors: tang k. Cancer Lett. 2015 Jan 28;356(2 Pt B):392-403. doi: 10.1016/j.canlet.2014.09.040. Epub 2014 Oct 7. Cancer Lett. 2015. PMID: 25301453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,479 results

Search Page

Filters